Early Detection: Digital Rectal Exam & PSA Test Prostate Cancer Screening | Roswell Park Comprehensive Cancer Center
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicine - ScienceDirect
A Systematic Review and Meta-analysis of the Effectiveness and Toxicities of Lutetium-177–labeled Prostate-specific Membrane Antigen–targeted Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer - European Urology
Survival Outcomes, Prostate-specific Antigen Response, and Tolerance in First and Later Lines of Enzalutamide Treatment for Metastatic Castration-resistant Prostate Cancer: A Real-World Experience in Hong Kong - Clinical Genitourinary Cancer
Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study | The BMJ
September is Prostate Cancer Awareness Month | Cookeville Regional Medical Center
Screening of peptide selectively recognizing prostate-specific antigen and its application in detecting total prostate-specific antigen - ScienceDirect
Case 9-2012 — A 67-Year-Old Man with a Persistently Elevated PSA Level | NEJM
Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study | British Journal of Cancer
ASCO GU 2020: Real-World Analysis of Prostate-Specific Antigen Outcomes Among Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide
Prostate‐specific antigen testing rates and referral patterns from general practice data in England - Moss - 2016 - International Journal of Clinical Practice - Wiley Online Library
Blue Earth Diagnostics Announces FDA Acceptance of New Drug Application for 18F-rhPSMA-7.3, a Radiohybrid Prostate-Specific Membrane Antigen-Targeted PET Imaging Agent for Prostate Cancer | Business Wire
Quantitative Analysis of Prostate Specific Antigen Isoforms Using Immunoprecipitation and Stable Isotope Labeling Mass Spectrometry | Analytical Chemistry
:max_bytes(150000):strip_icc()/2782267_color-5baa944e4cedfd00252b40ca.png "Prostate-Specific Antigen (PSA) Test: Purpose & Results")
Prostate-Specific Antigen (PSA) Test: Purpose & Results
Measurement of total and free prostate specific antigen (PSA) in human serum samples using an ultra-microanalytical system - ScienceDirect
Diagnostics | Free Full-Text | Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A ...
Prostate-specific antigen (PSA) test - Patient Information
Prostate cancer screening is no longer automatic. That's turned out to be a sensible change.
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer | NEJM
Prostate Specific Antigen (PSA) Test, Results, Levels & Ranges
The World Journal of Men's Health
Quality-of-Life Effects of Prostate-Specific Antigen Screening | NEJM
The PSA Test For Prostate Cancer: No Before, Now Maybe | KERA News
The World Journal of Men's Health
MRI phenotype of the prostate: Transition zone radiomics analysis improves explanation of prostate-specific antigen (PSA) serum level compared to volume measurement alone - European Journal of Radiology
